---
title: "VCANBIO's subsidiary VUM03 injection clinical trial application has received an acceptance notice"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/223783465.md"
description: "VCANBIO's wholly-owned subsidiary Wuhan Optics Valley VCANBIO Pharmaceutical Co., Ltd. received the Clinical Trial Application Acceptance Notice for VUM03 Injection issued by the Center for Drug Evaluation (CDE) of the National Medical Products Administration on December 31, 2024, with acceptance number CXSL2400934. This injection is a cryopreserved cell preparation independently developed by the company, aimed at treating non-active/mildly active Crohn's disease complex anal fistula"
datetime: "2025-01-02T09:59:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/223783465.md)
  - [en](https://longbridge.com/en/news/223783465.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/223783465.md)
generator: "portal-rs"
---

# VCANBIO's subsidiary VUM03 injection clinical trial application has received an acceptance notice

According to the Zhitong Finance APP, VCANBIO (600645.SH) announced that its wholly-owned subsidiary Wuhan Guanggu VCANBIO Pharmaceutical Co., Ltd. received the "Acceptance Notice" for the clinical trial application of VUM03 injection from the National Medical Products Administration's Center for Drug Evaluation (CDE) on December 31, 2024, with acceptance number CXSL2400934.

VUM03 injection (human umbilical cord-derived mesenchymal/stromal cell injection) is a cryopreserved cell preparation independently developed by our company, made from selected healthy newborn umbilical cord tissue through in vitro separation, expansion, harvesting, and cryopreservation to prepare human umbilical cord-derived mesenchymal/stromal cells (UC-MSC) new drug. This product is developed as a general-purpose, ready-to-use cell preparation to meet clinical local usage needs, and is intended for the treatment of non-active/mildly active Crohn's disease complex anal fistula

### Related Stocks

- [600645.CN](https://longbridge.com/en/quote/600645.CN.md)
- [MSC.US](https://longbridge.com/en/quote/MSC.US.md)
- [NPW.SG](https://longbridge.com/en/quote/NPW.SG.md)

## Related News & Research

- [Kalshi issues first lifetime ban for Republican politician over insider bets](https://longbridge.com/en/news/297684078.md)
- [TRON DAO Engages Brazilian Authorities at DCGG and CNMP Digital Asset Recovery Forum](https://longbridge.com/en/news/297382827.md)
- [California Moves to Shut Down Private Equity Takeovers of Law Firms](https://longbridge.com/en/news/297560908.md)
- [Zhongzi International seeks HKEX trading resumption from Sept. 1 after filing annual results](https://longbridge.com/en/news/297524727.md)
- [Kalshi suspends GOP House candidate in North Carolina for betting on own race](https://longbridge.com/en/news/297550301.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**